Last reviewed · How we verify
cassia seed tablet — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
cassia seed tablet (cassia seed tablet) — Calo Psychiatric Center.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| cassia seed tablet TARGET | cassia seed tablet | Calo Psychiatric Center | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- cassia seed tablet CI watch — RSS
- cassia seed tablet CI watch — Atom
- cassia seed tablet CI watch — JSON
- cassia seed tablet alone — RSS
Cite this brief
Drug Landscape (2026). cassia seed tablet — Competitive Intelligence Brief. https://druglandscape.com/ci/cassia-seed-tablet. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing